Lybrate.com has a number of highly qualified Gynaecologists in India. You will find Gynaecologists with more than 30 years of experience on Lybrate.com. You can find Gynaecologists online in Ahmedabad and from across India. View the profile of medical specialists and their reviews from other patients to make an informed decision.
Book Clinic Appointment with Dr. Meena C Amin
Caesarean Section Procedure
Treatment Of Female Sexual Problems
Termination Of Pregnancy Procedure
Treatment Of Pregnancy Problems
Well Woman Healthcheck
Treatment Of Female Sexual Problems
Treatment Of Medical Diseases In Pregnancy
Treatment Of Menstrual Problems
Intra-Uterine Insemination (IUI) Treatment
Medical Termination Of Pregnancy (Mtp) Procedure
Gynecology Laparoscopy Procedures
Pap Smear Procedure
Urinary Incontinence (Ui) Treatment
Submit a review for Dr. Meena C AminYour feedback matters!
Hello sir, actually I am about to get married. And I have PCOD problem. Would I have any problems to expect a baby or during pregnancy.
Dip your gentle Nails into warm Olive oil every once in a while for 15-20 minutes to make them hard.
New path to blood sugar control
Most dm drugs make pancrea to increase insulin other act on liver other act on body cell
To date, two of these new drugs have been approved by the u. S. Food and drug administration for treating type 2 diabetes. The first, canagliflozin (invokana®), was cleared last march; the second, dapagliflozin (farxiga®), was approved just this week.
Both drugs are so-called sglt2 inhibitors that act by blocking the kidneys’ reabsorption of sugar, or glucose. The result is that more glucose is released in the urine and the patient’s blood glucose level goes down — a major goal of diabetes treatment.
Most other available drugs for diabetes work by targeting the liver, pancreas or gut to improve insulin sensitivity, reduce insulin resistance or stimulate insulin secretion. In contrast, sglt2 inhibitors work completely independent of insulin.
The two new medications, which are taken by mouth in pill form, are approved for use as stand-alone drug therapy, in addition to changes in diet and increased exercise, or in combination with other drugs for diabetes. Their approvals were based on multiple clinical studies — nine for canagliflozin and 16 for dapagliflozin — showing that they effectively lowered hemoglobin a1c, a measure of average blood sugar level over the previous three months.
A surprise effect on the waistline
An added benefit is that sglt2 inhibitors are associated with modest weight loss. For instance, patients shed from 2.8 percent to 5.7 percent of body weight in clinical studies of canagliflozin.
“The weight loss is an appealing side effect of sglt2 inhibitors, especially in the growing population of obese individuals with type 2 diabetes,” says cleveland clinic endocrinologist mary vouyiouklis, md. “aside from metformin, which occasionally results in modest weight loss, other oral drugs used to treat type 2 diabetes are weight-neutral or can cause weight gain.”
Safety profile: keeping an eye on heart effects
Another potential benefit is also a potential adverse effect: the fact that sglt2 inhibitors have a mild diuretic effect (i. E, tend to increase urination). This results in lowering of blood pressure, which can be good for some patients who have high blood pressure but can also cause lightheadedness, dizziness or even fainting in other individuals. Dr. Vouyiouklis says caution is needed before these drugs are started in any patients at particular risk of the latter effects, such as the elderly or patients taking diuretics or multiple drugs for blood pressure.
The drugs’ other most common side effects in clinical trials — genital yeast infections and urinary tract infections — are also related to the fact that they act via the kidneys. Both drugs posed a low risk of hypoglycemia, the dangerously low blood sugar episodes associated with some diabetes therapies.
However, the new drugs were found to modestly increase levels of ldl (“bad”) cholesterol, which could be a concern because patients with diabetes are already at increased risk of heart disease. The potential for increased rates of heart attack, stroke and other cardiac events is being specifically monitored in large ongoing studies of both canagliflozin and dapagliflozin, but full results are not expected for several years.
Ongoing bladder safety scrutiny with dapagliflozin
Additionally, patients taking dapagliflozin in clinical trials showed a small increase in bladder cancer diagnoses compared with control patients. In fact, dapagliflozin was rejected for approval by the fda two years ago because of concerns over bladder cancer and liver toxicity.
The agency’s concerns about these risks were eased by additional data from dapagliflozin’s manufacturer this time around, but the drug’s approval included a requirement that it be studied for bladder cancer risk in patients in ongoing trials as well as in new animal studies looking specifically at effects on the bladder.
Canagliflozin does not appear to be associated with bladder cancer or liver toxicity, the fda concluded.
More agents in the pipeline
Several other sglt2 inhibitors may soon be available as well. One of them, empagliflozin, is in late-stage studies, and the fda is expected to decide on its approval by the end of march.
Who should get these drugs, and when?
Dr. Vouyiouklis says obese patients with type 2 diabetes and normal kidney function stand to benefit most from sglt2 inhibitors. In general, these drugs seem to be best tolerated by patients with normal kidney function and less well tolerated by those with moderate kidney disease (they should not be used by patients with severe kidney disease). They are not approved for use by pregnant women, patients under 18 or individuals with type 1 diabetes.
“Although sglt2 inhibitors are approved for use as single drug therapy, metformin remains my choice for first-line oral therapy,” says Dr. Vouyiouklis. “Because sglt2 inhibitors are relatively new and their long-term effects are not yet known, I prefer to reserve them for use as add-on therapy. I believe they will be a useful addition, especially in obese patients who are seeking to lose weight.”type diabetes
I am 33 years old female unmarried. I had my periods this month on 9th but on 19th I started bleeding again. It was little for 2 or 3 days but now bleeding is become more. What do I do to stop ties in between periods bleeding. This is first time tis is happening to me. Please do reply soon i am really tensed. Every month I used to get my periods on 31st but this time it happened on 24th day. Please reply.
I want to commence a regular exercising schedule gradually increasing the intensity. How should I alter my diet if absolutely no weight loss is intended? A little gain of muscle mass would be preferable.
I heard that after taking I pill there is bleeding but in our case yet no bleeding Hello doc. My cousin brother had unprotected sex on 15 th may, n his wife has taken ipill after 2 hours of intercourse, she expecting her period on 23 may n her last period date is 23 april, so if any problem there, they don't want child on this stage, so how much chances of pregnancy please ans me.
Terms like ileostomy and colostomy really sound a bit too scientific, don’t they? Well, it is true that may seem to be pretty scary to almost anybody who is not professionally familiar with them! That being said, it is quite important to know what these things are, as it is always good to be informed of things like these. After all, one never knows when he or she may need to consider the possibility of having one.
The similarity which exists between these two procedures is due to the fact that both of them require the surgeon to cut an opening into the intestine from the skin of the abdominal wall. To be more specific about each of the procedures, the ileostomy involves the removal of the entire colon as well as the rectum of the person who is undergoing it. When this operation is performed, the small intestine’s end is adapted so as to expel the faeces which are produced as a result of the digestive process.
Now, this does seem like quite a daunting prospect, does it not? Well, it does and with good reason as it is really not a small matter, at all. That is why the surgery is performed on people who suffer from diseases such as Crohn's disease, who have a condition in which entire sections of their gut cannot be linked in a proper manner!
On the other hand, a colostomy refers to a follow-up surgery to a colectomy, in which the surgeon creates an opening which is known as a stoma. A colectomy is when there is a removal of a part of the large intestine. In many cases of colostomies being performed, they are intended to be temporary in nature.
Now, taking into account just how serious these operations are, a person may wonder just what unfortunate thing needs to happen to warrant a surgery of this sort to be performed! Well, essentially, if there is an occurrence of bowel cancer which is significantly bad, then there may be a need which arises as a result of the same.
Advanced medicines do have some interesting facts; contrary to what most people think, a stoma does not hurt. This is because there are no nerves in the area! While a person may hopefully never need either surgery performed on oneself, that surely does not mean that awareness about them should not be widespread.
In case you have a concern or query you can always consult an expert & get answers to your questions!